Category: Medications - Page 3

The FDA ensures generic drug quality through strict cGMP standards, unannounced inspections, and rigorous testing of every manufacturing step - not just the final product. This system keeps 90% of U.S. prescriptions safe and affordable.

Learn how to report counterfeit or tampered medications safely and effectively. Step-by-step guidance for patients, pharmacists, and supply chain workers to help stop dangerous fake drugs from harming others.

Learn how to talk to your doctor about generic vs. brand-name medications-why generics are just as effective, when to ask for the brand, and how to save money without risking your health.

Switching from brand to generic drugs saves money, but not everyone has the same experience. Learn when it’s safe, when to be cautious, and what to do if you feel worse after the switch.

Learn how to choose between generic and brand-name medications safely and affordably. Discover when generics work just as well, when to stick with brand, and how to avoid common pitfalls that affect adherence and health outcomes.

Learn how coffee interferes with levothyroxine absorption and why waiting 60 minutes after taking your thyroid medication can make a huge difference in your energy, mood, and overall health.

Dechallenge and rechallenge are clinical methods used to confirm if a drug caused an adverse reaction. Stopping the drug (dechallenge) and, if safe, restarting it (rechallenge) provide the strongest evidence of causality in pharmacovigilance.

Learn how to set realistic, personalized medication adherence goals using the B-SMART framework and simple tracking methods that actually work in real life - no apps required.

Switching to generic medications saves money, but long-term health outcomes aren't always guaranteed. Learn how manufacturing differences, frequent switches, and lack of long-term data can affect stability-and what you can do to protect your health.

China and India dominate global pharmaceutical manufacturing, but FDA monitoring reveals stark differences in compliance. India leads in regulatory reliability, while China offers scale - but with higher risk. Here’s how it affects drug safety.